AUD 0.01
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 | 267.7 Thousand AUD | -98.03% |
2023 | 13.6 Million AUD | 11.96% |
2022 | 12.15 Million AUD | 4.96% |
2021 | 11.57 Million AUD | 20.59% |
2020 | 9.6 Million AUD | -28.93% |
2019 | 13.5 Million AUD | -6.25% |
2018 | 14.4 Million AUD | -5.61% |
2017 | 15.26 Million AUD | 97.79% |
2016 | 7.71 Million AUD | 139.13% |
2015 | 3.22 Million AUD | 32.43% |
2014 | 2.43 Million AUD | 381.19% |
2013 | 506.42 Thousand AUD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 FY | 11.34 Million AUD | -16.61% |
2024 Q4 | 6.14 Million AUD | 0.0% |
2024 Q2 | 5.19 Million AUD | 0.0% |
2023 FY | 13.6 Million AUD | 11.96% |
2023 Q4 | 6.64 Million AUD | 0.0% |
2023 Q2 | 6.93 Million AUD | 0.0% |
2022 Q4 | 6.37 Million AUD | 0.0% |
2022 FY | 12.15 Million AUD | 4.96% |
2022 Q2 | 5.77 Million AUD | 0.0% |
2021 Q2 | 6.77 Million AUD | 0.0% |
2021 Q4 | 4.43 Million AUD | 0.0% |
2021 FY | 11.57 Million AUD | 20.59% |
2020 Q2 | 4.21 Million AUD | 0.0% |
2020 Q4 | 5.27 Million AUD | 0.0% |
2020 FY | 9.6 Million AUD | -28.93% |
2019 FY | 13.5 Million AUD | -6.25% |
2019 Q4 | 4.01 Million AUD | 0.0% |
2019 Q2 | 9.2 Million AUD | 0.0% |
2018 Q4 | 7.22 Million AUD | 0.0% |
2018 Q2 | 7.18 Million AUD | 0.0% |
2018 FY | 14.4 Million AUD | -5.61% |
2017 Q2 | 5.83 Million AUD | 0.0% |
2017 FY | 15.26 Million AUD | 97.79% |
2017 Q4 | 8.75 Million AUD | 0.0% |
2016 FY | 7.71 Million AUD | 139.13% |
2015 Q2 | - AUD | 0.0% |
2015 FY | 3.22 Million AUD | 32.43% |
2015 Q3 | - AUD | 0.0% |
2014 FY | 2.43 Million AUD | 381.19% |
2013 FY | 506.42 Thousand AUD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
4DMedical Limited | 31.48 Million AUD | 99.15% |
Aroa Biosurgery Limited | 66.09 Million AUD | 99.595% |
Atomo Diagnostics Limited | 1.6 Million AUD | 83.331% |
Anteris Technologies Ltd | 69.14 Million AUD | 99.613% |
Control Bionics Limited | 9.82 Million AUD | 97.276% |
CardieX Limited | 16.64 Million AUD | 98.392% |
Compumedics Limited | 26.88 Million AUD | 99.004% |
Cochlear Limited | 1.17 Billion AUD | 99.977% |
CleanSpace Holdings Limited | 11.35 Million AUD | 97.643% |
Cyclopharm Limited | 13.38 Million AUD | 97.999% |
EMVision Medical Devices Ltd | 12.83 Million AUD | 97.914% |
Nova Eye Medical Limited | 23.99 Million AUD | 98.884% |
HeraMED Limited | 6.78 Million AUD | 96.053% |
Imricor Medical Systems, Inc. | -1.11 Million AUD | 123.991% |
ImpediMed Limited | 28.04 Million AUD | 99.045% |
InhaleRx Limited | 2.59 Million AUD | 89.666% |
LBT Innovations Limited | 1.1 Million AUD | 75.817% |
Micro-X Limited | 18.76 Million AUD | 98.573% |
Neurotech International Limited | 8.75 Million AUD | 96.942% |
OncoSil Medical Limited | 12.03 Million AUD | 97.777% |
PolyNovo Limited | 34.92 Million AUD | 99.233% |
Respiri Limited | 8.03 Million AUD | 96.668% |
SomnoMed Limited | 58.97 Million AUD | 99.546% |
Universal Biosensors, Inc. | 20 Million AUD | 98.662% |
Uscom Limited | 5.52 Million AUD | 95.15% |
Visioneering Technologies, Inc. | 9.63 Million AUD | 97.221% |